PDL BioPharma (FRA:PDL) Total Long-Term Assets : €22.30 Mil (As of Jun. 2020)

View and export this data going back to 2006. Start your Free Trial

What is PDL BioPharma Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. PDL BioPharma's Total Long-Term Assets for the quarter that ended in Jun. 2020 was €22.30 Mil.

PDL BioPharma Total Long-Term Assets Historical Data

The historical data trend for PDL BioPharma's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PDL BioPharma Total Long-Term Assets Chart

PDL BioPharma Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Total Long-Term Assets

Get a 7-Day Free Trial

669.68

774.85

509.27

392.49

362.00

PDL BioPharma Quarterly Data
	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
Total Long-Term Assets	Get a 7-Day Free Trial															434.32	416.10	362.00	98.24	22.30

PDL BioPharma Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

PDL BioPharma Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of PDL BioPharma's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

PDL BioPharma (FRA:PDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PDL BioPharma Inc (FRA:PDL) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

932 Southwood Boulevard, Incline Villiage, NV, USA, 89451

Website

http://www.pdl.com

PDL BioPharma Inc acquires and manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries. The operating segments of the company are Medical Devices, Strategic Positions, Pharmaceutical and Income Generating Assets, of which key revenue is derived from the Pharmaceutical segment. The Pharmaceutical segment consists of revenue derived from branded prescription medicine products sold under the name Tekturna and Tekturna HCT in the U.S, and Rasilez and Rasilez HCT in the rest of the world (collectively, the Noden Products). Geographically, the company operates in Europe, North America, Asia and Other countries, of which prime revenue is generated from Asia and North America.

PDL BioPharma (FRA:PDL) Headlines

No Headlines